The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Response to immune checkpoint inhibition as monotherapy or in combination with chemotherapy in metastatic ROS1-rearranged lung cancers.
 
Noura J. Choudhury
No Relationships to Disclose
 
Jaime Laurel Schneider
No Relationships to Disclose
 
Tejas Patil
Stock and Other Ownership Interests - crispr therapeutics; Guardant Health; Novartis; Pfizer; Roche/Genentech
Honoraria - Aptitude Health; AstraZeneca; Physicans' Education Resource; Roche/Genentech
Consulting or Advisory Role - Guidepoint Global
 
Viola Weijia Zhu
Stock and Other Ownership Interests - TP Therapeutics; TP Therapeutics (I)
Honoraria - AstraZeneca; Blueprint Medicines; Roche/Genentech; Takeda; Xcovery
Consulting or Advisory Role - AstraZeneca; Roche/Genentech; Takeda; TP Therapeutics; Xcovery
Speakers' Bureau - AstraZeneca; Blueprint Medicines; Roche/Genentech; Takeda
Travel, Accommodations, Expenses - AstraZeneca; Roche/Genentech; Takeda; TP Therapeutics
 
Debra A. Goldman
Stock and Other Ownership Interests - Johnson & Johnson
 
Soo-Ryum Yang
Consulting or Advisory Role - InVitae
 
Christina Falcon
No Relationships to Disclose
 
Andrew Do
No Relationships to Disclose
 
Yunan Nie
No Relationships to Disclose
 
Andrew J. Plodkowski
No Relationships to Disclose
 
Jamie E. Chaft
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Flame Biosciences; Genentech/Roche; Merck
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck (Inst)
 
Subba Digumarthy
Honoraria - Siemens Healthineers
Consulting or Advisory Role - Abbvie; Bayer; Bristol-Myers Squibb; Cascadian Therapeutics; Gradalis; Merck; Novartis; Pfizer; Polaris; Roche; Zai Lab
Research Funding - Lunit
 
Natasha Rekhtman
Honoraria - Physicans' Education Resource
 
Maria E. Arcila
Honoraria - Biocartis; Invivoscribe
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca; Invivoscribe; Raindance Technologies
 
Alexia Iasonos
Stock and Other Ownership Interests - Bristol-Myers Squibb/Sanofi
Consulting or Advisory Role - BrightPath Biotheraputics; Intelligencia; Mylan
 
Sai-Hong Ignatius Ou
Stock and Other Ownership Interests - Elevation Oncology; Turning Point Therapeutics
Honoraria - ARIAD/Takeda; AstraZeneca; Genentech/Roche; Pfizer; Roche Pharma AG
Consulting or Advisory Role - AstraZeneca; Janssen; Pfizer; Roche/Genentech; Takeda
Speakers' Bureau - AstraZeneca; Genentech/Roche
Research Funding - ARIAD (Inst); AstraZeneca (Inst); AstraZeneca/MedImmune (Inst); Janssen (Inst); Mirati Therapeutics (Inst); Pfizer (Inst); Revolution Medicines (Inst); Roche Pharma AG (Inst)
 
Jessica Jiyeong Lin
Honoraria - OncLive; Pfizer
Consulting or Advisory Role - Blueprint Medicines; C4 Therapeutics; Genentech; Nuvalent, Inc.; Turning Point Therapeutics; Turning Point Therapeutics
Research Funding - Bayer (Inst); Elevation Oncology (Inst); Hengrui Therapeutics (Inst); Neon Therapeutics (Inst); Novartis (Inst); Relay Therapeutics (Inst); Roche (Inst); Turning Point Therapeutics (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Alexander E. Drilon
Honoraria - Foundation Medicine; Medscape; MORE Health; OncLive; Peerview; PeerVoice; Physicans' Education Resource; Research to Practice; Targeted Oncology
Consulting or Advisory Role - 14ner Oncology/Elevation Oncology; Abbvie; Archer; AstraZeneca; Bayer; BeiGene; BerGenBio; Blueprint Medicines; EMD Serono/Merck; Exelixis; Genentech/Roche; Helsinn Therapeutics; Hengrui Therapeutics; Ignyta; Lilly; Loxo; Melendi; Monopteros Therapeutics; Monopteros Therapeutics; MORE Health; Novartis; Pfizer; Remedica; Repare Therapeutics; Takeda/Millennium; TP Therapeutics; Tyra Biosciences; Verastem; Verastem
Research Funding - Foundation Medicine
Patents, Royalties, Other Intellectual Property - Wolters Kluwer (Royalties for Pocket Oncology)
Other Relationship - GlaxoSmithKline; Merck; Pfizer; PharmaMar; Puma Biotechnology; Taiho Pharmaceutical; Teva